The HOTWIREâ„¢ Transseptal Access System combines a novel RF guidewire with a next-generation RF generator designed to optimize transseptal access, streamline procedural workflows and improve patient ...
MemorialCare Heart & Vascular Institute at Long Beach Medical Center is one of only two California sites participating in the global RESPONDER HF trial evaluating the Corvia (R) Atrial Shunt for ...
Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation ...
Patients who have had an embolic stroke of undetermined source (ESUS) and have moderate-to-severe left atrial enlargement may benefit from empiric treatment with a direct oral anticoagulant (DOAC), a ...
Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...
Medtronic (NYSE:MDT) reported new positive post-market clinical evidence for its Penditure left atrial appendage (LAA) ...
Convergent hybrid ablation is an innovative treatment for a type of irregular heart rhythm called atrial fibrillation (AFib). The treatment is a two-stage procedure that combines the expertise of our ...
While the smartphone app and bed sensor enhanced AF detection, high false alarm rates limit their suitability for routine ...
Previously, patients with advanced atrial fibrillation (AF/AFib) had limited treatment choices. Since February 2024, West ...
Diastolic dysfunction occurs when the left ventricular myocardium is non-compliant and not able to accept blood return in a normal fashion from the left atrium. This can be a normal physiologic change ...